CT
AMED

Clearstead Trust’s Amedisys AMED Stock Holding History

Clearstead Trust’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$9.84K – 1513
2025
Q2 		$9.84K Buy
100
+36
+56% +$3.41K ﹤0.01% 594
2025
Q1 		$5.93K Buy
+64
New +$5.9K ﹤0.01% 560

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Clearstead Trust's AMED Position: Q3 2025 in Review

Clearstead Trust sold out of Amedisys (AMED) in Q3 2025, closing a stake of 100 shares — an estimated $9.84K sold.

Clearstead Trust first reported a position in AMED in Q1 2025 and held it in 2 quarters. The position peaked at $9.84K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Clearstead Trust reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Clearstead Trust sold 100 Amedisys shares in Q3 2025, an estimated $9.84K.
  • Clearstead Trust first reported a position in Amedisys in Q1 2025 and held it in 2 quarters.
  • Clearstead Trust's Amedisys position peaked at $9.84K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Clearstead Trust's 13F filing for Q3 2025, filed 10 Nov 2025.